These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16914052)

  • 1. An examination of periodontal treatment and per member per month (PMPM) medical costs in an insured population.
    Albert DA; Sadowsky D; Papapanou P; Conicella ML; Ward A
    BMC Health Serv Res; 2006 Aug; 6():103. PubMed ID: 16914052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal treatment associated with decreased diabetes mellitus-related treatment costs: An analysis of dental and medical claims data.
    Thakkar-Samtani M; Heaton LJ; Kelly AL; Taylor SD; Vidone L; Tranby EP
    J Am Dent Assoc; 2023 Apr; 154(4):283-292.e1. PubMed ID: 36841690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value for the money spent? Exploring the relationship between expenditures, insurance adequacy, and access to care for publicly insured children.
    Colby MS; Lipson DJ; Turchin SR
    Matern Child Health J; 2012 Apr; 16 Suppl 1():S51-60. PubMed ID: 22476794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health Care Expenditures Among Adults With Diabetes After Oregon's Medicaid Expansion.
    Lindner SR; Marino M; O'Malley J; Angier H; Bailey SR; Hoopes M; Springer R; McConnell KJ; DeVoe J; Huguet N
    Diabetes Care; 2020 Mar; 43(3):572-579. PubMed ID: 31857442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of periodontal therapy on general health: evidence from insurance data for five systemic conditions.
    Jeffcoat MK; Jeffcoat RL; Gladowski PA; Bramson JB; Blum JJ
    Am J Prev Med; 2014 Aug; 47(2):166-74. PubMed ID: 24953519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of periodontal disease on medical and dental costs in a middle-aged Japanese population: a longitudinal worksite study.
    Ide R; Hoshuyama T; Takahashi K
    J Periodontol; 2007 Nov; 78(11):2120-6. PubMed ID: 17970678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost and utilization of behavioral health medications associated with rescission of an exemption for prior authorization for severe and persistent mental illness in the Vermont Medicaid Program.
    Simeone JC; Marcoux RM; Quilliam BJ
    J Manag Care Pharm; 2010 Jun; 16(5):317-28. PubMed ID: 20518584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of periodontal treatment, dental care, and pregnancy outcomes in an insured population in the United States.
    Albert DA; Begg MD; Andrews HF; Williams SZ; Ward A; Conicella ML; Rauh V; Thomson JL; Papapanou PN
    Am J Public Health; 2011 Jan; 101(1):151-6. PubMed ID: 21088265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic costs of diabetes in the US in 2002.
    Hogan P; Dall T; Nikolov P;
    Diabetes Care; 2003 Mar; 26(3):917-32. PubMed ID: 12610059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of medication therapy management services for patients with cardiovascular disease in a self-insured employer health plan.
    Wittayanukorn S; Westrick SC; Hansen RA; Billor N; Braxton-Lloyd K; Fox BI; Garza KB
    J Manag Care Pharm; 2013 Jun; 19(5):385-95. PubMed ID: 23697476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periodontal treatment and subsequent clinical outcomes and medical care costs: A retrospective cohort study.
    Michalowicz BS; Anderson JP; Kottke TE; Dehmer SP; Worley DC; Kane S; Basile S; Rindal DB
    PLoS One; 2023; 18(8):e0290028. PubMed ID: 37578943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.
    Gandra SR; Lawrence LW; Parasuraman BM; Darin RM; Sherman JJ; Wall JL
    J Manag Care Pharm; 2006 Sep; 12(7):546-54. PubMed ID: 16981800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics of periodontal diseases.
    Brown LJ; Johns BA; Wall TP
    Periodontol 2000; 2002; 29():223-34. PubMed ID: 12102710
    [No Abstract]   [Full Text] [Related]  

  • 16. Periodontal diseases in North America.
    Albandar JM
    Periodontol 2000; 2002; 29():31-69. PubMed ID: 12102702
    [No Abstract]   [Full Text] [Related]  

  • 17. All-cause and potentially disease-related health care costs associated with venous thromboembolism in commercial, Medicare, and Medicaid beneficiaries.
    Lefebvre P; Laliberté F; Nutescu EA; Duh MS; LaMori J; Bookhart BK; Olson WH; Dea K; Schein J; Kaatz S
    J Manag Care Pharm; 2012 Jun; 18(5):363-74. PubMed ID: 22663169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated Budget Impact of Increased Use of Mirabegron, A Novel Treatment for Overactive Bladder.
    Perk S; Wielage RC; Campbell NL; Klein TM; Perkins A; Posta LM; Yuran T; Klein RW; Ng DB
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1072-84. PubMed ID: 27579830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the effect of a consumer-driven health plan on medical care expenditures and utilization.
    Parente ST; Feldman R; Christianson JB
    Health Serv Res; 2004 Aug; 39(4 Pt 2):1189-210. PubMed ID: 15230920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.